Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Istanbul Training and Research Hospital
Regeneron Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Jonsson Comprehensive Cancer Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Novartis
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Bispebjerg Hospital
NYU Langone Health
Melanoma and Skin Cancer Trials Limited
University of Southern California
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
Regeneron Pharmaceuticals
Tempus AI
Maastricht University Medical Center
Alpha Tau Medical LTD.
Barco NV
Checkpoint Therapeutics, Inc.
Northwestern University
Harvard School of Public Health (HSPH)